Citation: E. De Klerk, Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder, J CLIN PSY, 62, 2001, pp. 43-47
Authors:
Claxton, A
de Klerk, E
Parry, M
Robinson, JM
Schmidt, ME
Citation: A. Claxton et al., Patient compliance to a new enteric-coated weekly formulation of fluoxetine during continuation treatment of major depressive disorder, J CLIN PSY, 61(12), 2000, pp. 928-932
Authors:
Spoorenberg, A
van der Heijde, D
de Klerk, E
Dougados, M
de Vlam, K
Mielants, H
van der Tempel, H
van der Linden, S
Citation: A. Spoorenberg et al., A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis, J RHEUMATOL, 26(4), 1999, pp. 961-965
Authors:
Spoorenberg, A
van der Heijde, D
de Klerk, E
Dougados, M
de Vlam, K
Mielants, H
van der Tempel, H
van der Linden, S
Citation: A. Spoorenberg et al., Relative value of erythrocyte sedimentation rate and C-reactive protein inassessment of disease activity in ankylosing spondylitis, J RHEUMATOL, 26(4), 1999, pp. 980-984
Authors:
Spoorenberg, A
de Vlam, K
van der Heijde, D
de Klerk, E
Dougados, M
Mielants, H
van der Tempel, H
Boers, M
van der Linden, S
Citation: A. Spoorenberg et al., Radiological scoring methods in ankylosing spondylitis: Reliability and sensitivity to change over one year, J RHEUMATOL, 26(4), 1999, pp. 997-1002
Authors:
de Klerk, E
van der Heijde, D
van der Tempel, H
van der Linden, S
Citation: E. De Klerk et al., Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy, J RHEUMATOL, 26(12), 1999, pp. 2635-2641
Citation: E. De Klerk et al., Primal-dual potential reduction methods for semidefinite programming usingaffine-scaling directions, APPL NUM M, 29(3), 1999, pp. 335-360